![1-[(3R)-6,8-Difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl…](https://static.cymitquimica.com/cas-image/493109-1-3r-68-difluoro-34-dihydro-2h-1-benzopyran-3-yl-13-dihydro-5-2-phenylmethyl-amino-ethyl-2h-imidazole-2-thione.png)
CAS: 1080028-80-3 - 1-[(3R)-6,8-Difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-2H-imidazole-2-thione
Formel:C21H21F2N3OS
InChl:InChI=1S/C21H21F2N3OS/c22-16-8-15-9-18(13-27-20(15)19(23)10-16)26-17(12-25-21(26)28)6-7-24-11-14-4-2-1-3-5-14/h1-5,8,10,12,18,24H,6-7,9,11,13H2,(H,25,28)/t18-/m1/s1
InChI Key:InChIKey=ZSSLCFLHEFXANG-GOSISDBHSA-N
SMILES:FC=1C=C(F)C=2OCC(N3C(=S)NC=C3CCNCC=4C=CC=CC4)CC2C1
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Zamicastat REF: TM-T13383CAS: 1080028-80-3 | 99.58% | 96,00 €~1.201,00 € | Fr 29 Nov 24 |
 | Zamicastat REF: 3D-FTB02880CAS: 1080028-80-3 | Min. 95% | Nachfragen | Do 09 Jan 25 |
Zamicastat
CAS:1080028-80-3
Zamicastat (BIA 5-1058) inhibits DBH, P-gp (IC50=73.8μM), and BCRP (IC50=17.0μM).
Formel:
C21H21F2N3OS
Reinheit:
99.58%
Farbe und Form:
Solid
Molekulargewicht:
401.47
Ref: TM-T13383
| 1mg | 96,00 € | ||
| 5mg | 202,00 € | ||
| 10mg | 305,00 € | ||
| 25mg | 551,00 € | ||
| 50mg | 828,00 € | ||
| 100mg | 1.201,00 € | ||
| 200mg | 903,00 € | ||
| 1mL*10mM (DMSO) | 219,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 29. November 2024
Zamicastat
CAS:1080028-80-3
Zamicastat is a drug that is used in the treatment of vascular dementia, including multi-infarct …
Formel:
C21H21F2N3OS
Reinheit:
Min. 95%
Molekulargewicht:
401.5 g/mol
Ref: 3D-FTB02880
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen | ||
| 100mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 9. Januar 2025
